WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

D DERMATOLOGICALS

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.


D05 ANTIPSORIATICS
D05A ANTIPSORIATICS FOR TOPICAL USE

This group comprises products for topical use mainly for the treatment of psoriasis. Corticosteroids for topical use are classified in
D07 - Corticosteroids, dermatological preparations.


D05AA Tars

All tar preparations for dermatological use are classified in this group, except for combinations with corticosteroids.

D05AC Antracen derivatives
D05AD Psoralens for topical use
D05AX Other antipsoriatics for topical use

Corticosteroids in combination with vitamin D analogues indicated only for the treatment of psoriasis are classified in D05AX.

Last updated: 2024-01-26